Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Opposing Effects of KDM6A and JDP2 on Glucocorticoid Sensitivity in T-ALL.

  • Read more about Opposing Effects of KDM6A and JDP2 on Glucocorticoid Sensitivity in T-ALL.

Combinatorial targeting of epigenome-modifying enzymes with small molecule drugs synergistically increases HbF.

  • Read more about Combinatorial targeting of epigenome-modifying enzymes with small molecule drugs synergistically increases HbF.

HLH-like toxicities predict poor survival following use of tisagenlecleucel in children and young adults with B-ALL.

  • Read more about HLH-like toxicities predict poor survival following use of tisagenlecleucel in children and young adults with B-ALL.

Histone Deacetylase-6 Modulates the Effects of 4oC Platelets on Vascular Endothelial Permeability.

  • Read more about Histone Deacetylase-6 Modulates the Effects of 4oC Platelets on Vascular Endothelial Permeability.

The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry.

  • Read more about The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry.

Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium.

  • Read more about Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.

  • Read more about Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

  • Read more about American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

A simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.

  • Read more about A simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.

JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β.

  • Read more about JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β.

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Blood advances

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List